Literature DB >> 32102562

Targeting cancer stem cells from a metabolic perspective.

Yao-An Shen1,2, Siao-Cian Pan3, I Chu1, Ruo-Yun Lai4, Yau-Huei Wei3.   

Abstract

Entities:  

Keywords:  Cancer stem cell; HIF; Myc; metabolic reprogramming; p53

Mesh：

Year:  2020        PMID： 32102562      PMCID： PMC7082881          DOI： 10.1177/1535370220909309

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  117 in total

1.  P53 mutations and cancer: a tight linkage.

Authors:  Francesco Perri; Salvatore Pisconti; Giuseppina Della Vittoria Scarpati
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  The paradigm of mutant p53-expressing cancer stem cells and drug resistance.

Authors:  Yoav Shetzer; Hilla Solomon; Gabriela Koifman; Alina Molchadsky; Stav Horesh; Varda Rotter
Journal:  Carcinogenesis       Date:  2014-03-21       Impact factor: 4.944

3.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.

Authors:  Andrea Viale; Piergiorgio Pettazzoni; Costas A Lyssiotis; Haoqiang Ying; Nora Sánchez; Matteo Marchesini; Alessandro Carugo; Tessa Green; Sahil Seth; Virginia Giuliani; Maria Kost-Alimova; Florian Muller; Simona Colla; Luigi Nezi; Giannicola Genovese; Angela K Deem; Avnish Kapoor; Wantong Yao; Emanuela Brunetto; Ya'an Kang; Min Yuan; John M Asara; Y Alan Wang; Timothy P Heffernan; Alec C Kimmelman; Huamin Wang; Jason B Fleming; Lewis C Cantley; Ronald A DePinho; Giulio F Draetta
Journal:  Nature       Date:  2014-08-10       Impact factor: 49.962

4.  LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.

Authors:  Cuilan Li; Vincent Wing Sun Liu; David Wai Chan; Kwok Ming Yao; Hextan Yuen Sheung Ngan
Journal:  Int J Gynecol Cancer       Date:  2012-01       Impact factor: 3.437

5.  BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Authors:  Eleni D Lagadinou; Alexander Sach; Kevin Callahan; Randall M Rossi; Sarah J Neering; Mohammad Minhajuddin; John M Ashton; Shanshan Pei; Valerie Grose; Kristen M O'Dwyer; Jane L Liesveld; Paul S Brookes; Michael W Becker; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2013-01-17       Impact factor: 24.633

Review 6.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

7.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

8.  Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4).

Authors:  Abhijeet Deshmukh; Frank Arfuso; Philip Newsholme; Arun Dharmarajan
Journal:  Cancers (Basel)       Date:  2018-01-31       Impact factor: 6.639

9.  Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.

Authors:  Binghua Li; Yajuan Cao; Gang Meng; Liyuan Qian; Tiancheng Xu; Chen Yan; Ouyang Luo; Shaohe Wang; Jiwu Wei; Yitao Ding; Decai Yu
Journal:  EBioMedicine       Date:  2018-12-13       Impact factor: 8.143

10.  Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells.

Authors:  Bai Cui; Yuanyuan Luo; Pengfei Tian; Fei Peng; Jinxin Lu; Yongliang Yang; Qitong Su; Bing Liu; Jiachuan Yu; Xi Luo; Liu Yin; Wei Cheng; Fan An; Bin He; Dapeng Liang; Sijin Wu; Peng Chu; Luyao Song; Xinyu Liu; Huandong Luo; Jie Xu; Yujia Pan; Yang Wang; Dangsheng Li; Peng Huang; Qingkai Yang; Lingqiang Zhang; Binhua P Zhou; Suling Liu; Guowang Xu; Eric W-F Lam; Keith W Kelley; Quentin Liu
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808
View more
  6 in total

Review 1.  The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment.

Authors:  Asieh Emami Nejad; Simin Najafgholian; Alireza Rostami; Alireza Sistani; Samaneh Shojaeifar; Mojgan Esparvarinha; Reza Nedaeinia; Shaghayegh Haghjooy Javanmard; Marjan Taherian; Mojtaba Ahmadlou; Rasoul Salehi; Bahman Sadeghi; Mostafa Manian
Journal:  Cancer Cell Int       Date:  2021-01-20       Impact factor: 5.722

2.  Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics.

Authors:  Shiv Verma; Eswar Shankar; F Naz Cemre Kalayci; Amrita Mukunda; Malek Alassfar; Vaibhav Singh; E Ricky Chan; Gregory T MacLennan; Sanjay Gupta
Journal:  Int J Mol Sci       Date:  2020-12-16       Impact factor: 5.923

Review 3.  Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer.

Authors:  Yifeng Mao; Gaowei Yang; Yingbang Li; Guowu Liang; Wangwang Xu; Mingqiu Hu
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

Review 4.  Natural Compounds as Metabolic Modulators of the Tumor Microenvironment.

Authors:  Ana S Dias; Luisa Helguero; Catarina R Almeida; Iola F Duarte
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

5.  Role of hypoxia inducible factor-1 in cancer stem cells (Review).

Authors:  Qi Zhang; Zhenzhen Han; Yanbo Zhu; Jingcheng Chen; Wei Li
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

6.  Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy.

Authors:  Masae Kishi; Afag Asgarova; Christophe Desterke; Diana Chaker; Jérôme Artus; Ali G Turhan; Annelise Bennaceur-Griscelli; Frank Griscelli
Journal:  Front Med (Lausanne)       Date:  2021-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.